Sanjay Vyas is President of Safety & Logistics and Country Head of India for Parexel. In this role he is responsible for the company’s global Clinical Trial Supplies & Logistics (CTS&L) operations, including its six global clinical supply distribution centers. He also sets the strategic direction and provides the leadership and vision to grow Parexel’s India operations, which include 6,000+ employees. Sanjay brings to the role more than 23 years of experience in global profit and loss management in life sciences and other service industries, including logistics and supply chain management, sales and marketing, mergers and acquisitions and operations and people management. Prior to Parexel, Sanjay was Vice President, Life Sciences and Healthcare APAC for DHL responsible for managing the Global Logistics & Supply Chain business for top life science and healthcare customers across all DHL business units within APAC. He also served as a member of the DHL Life Sciences and Healthcare Board. Sanjay completed the Advanced Management Program at Harvard Business School. He earned a Master of Marketing Management from the University of Mumbai and a Bachelor's in Commerce and Economics from Somaiya College of Arts & Commerce. He also holds a Professional Diploma in Software Technology and Systems Management from the National Institute of Information Technology.
Pharmacovigilance is undergoing a paradigm shift—from retrospective reporting to a proactive, predictive model that can anticipate and prevent adverse drug reactions. This session explores how the integration of real-world data, artificial intelligence, and pharmacogenomics is transforming drug safety into a precision discipline. Through real-world examples and strategic insights, attendees will gain a clear understanding of how to operationalize this evolution. The session concludes with a forward-looking call to action, empowering pharmacovigilance leaders to champion this transformation and drive safer patient outcomes worldwide.